drugset / Trial / NCT00237874

Aripiprazole Treatment of Prodromal Patients

NCT00237874

Phase 2/3 Completed 15 enrolled Yale University Bristol-Myers Squibb · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

We hypothesize that symptoms will improve in patients who meet diagnostic criteria for the schizophrenia prodrome when they are prescribed aripiprazole.

Timeline

Start
2004-02
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified

Indications